View this email in your browser ([link removed])


** March Update
------------------------------------------------------------

It's been a while, but the Bull Moose Project has been up to great work!

On March 12, I hosted a panel covering software procurement weaknesses and innovation within the Department in Defense titled 21st Century Warfare in the Capitol Building. Videos to come!


** America First Manufacturing Means Producing Plastic Here In America
------------------------------------------------------------

"Our small towns and rural communities are the bedrock of America’s greatness. Biden administration policies undermined the vitality of the American heartland, pushing jobs overseas and weakening our rural economies. President Donald Trump can restore American strength by revitalizing our home-grown manufacturing sector, which will reinvigorate economic life throughout the heartland.

It is time to put American jobs and the American economy first. This means recognizing the value of “Made in America”—and doing what we can to kickstart the revival of domestic manufacturing. It requires making sure that our industrial producers can reliably get the materials essential for building their products. For manufacturing, that core set of inputs includes plastics..."
Continue Reading ([link removed])


** The FDA just made Ozempic even more expensive — here’s how
------------------------------------------------------------


"Novo Nordisk relies heavily on the American market, with more than half of its sales coming from the United States. This dominance helped sustain Denmark’s economy, preventing a recession.

The company's dependence on U.S. consumers is reflected in its steep pricing. Ozempic costs $900 per month, while Wegovy is priced at $1,300 — a prohibitive expense for many Americans. For a time, an affordable alternative existed. When the federal government declared a semaglutide shortage, compounding pharmacies were allowed to produce lower-cost versions, offering them for hundreds of dollars less than the brand-name drugs.

That changed in February. Holdovers from the Biden administration declared the shortage over and set a deadline for compounding pharmacies to stop selling semaglutide alternatives. This move effectively drove the drug’s cost from under $200 back to more than $1,000..."
Continue Reading ([link removed])
[link removed]
[link removed]
bullmooseproject.org
Bull Moose Project | 300 Independence Ave SE, Washington, D.C. 20003
Update your preferences ([link removed]) [link removed] unsubscribe ([link removed]) .

============================================================